ID D6QM25_9HEPC Unreviewed; 1651 AA. AC D6QM25; DT 13-JUL-2010, integrated into UniProtKB/TrEMBL. DT 13-JUL-2010, sequence version 1. DT 16-NOV-2011, entry version 12. DE RecName: Full=Genome polyprotein; DE Flags: Fragment; OS Hepatitis C virus. OC Viruses; ssRNA positive-strand viruses, no DNA stage; Flaviviridae; OC Hepacivirus. OX NCBI_TaxID=11103; RN [1] RP NUCLEOTIDE SEQUENCE. RC STRAIN=30vSDc21_y00; RX PubMed=20200239; DOI=10.1128/JVI.02265-09; RA Liu L., Fisher B.E., Dowd K.A., Astemborski J., Cox A.L., Ray S.C.; RT "Acceleration of hepatitis C virus envelope evolution in humans is RT consistent with progressive humoral immune selection during the RT transition from acute to chronic infection."; RL J. Virol. 84:5067-5077(2010). CC -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate. CC -!- CATALYTIC ACTIVITY: NTP + H(2)O = NDP + phosphate. CC -!- SIMILARITY: Contains 1 helicase ATP-binding domain. CC -!- SIMILARITY: Contains 1 helicase C-terminal domain. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; HM000525; ADG34859.1; -; Genomic_RNA. DR euHCVdb; HM000525; -. DR GO; GO:0033644; C:host cell membrane; IEA:UniProtKB-KW. DR GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. DR GO; GO:0030529; C:ribonucleoprotein complex; IEA:UniProtKB-KW. DR GO; GO:0019028; C:viral capsid; IEA:UniProtKB-KW. DR GO; GO:0019031; C:viral envelope; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro. DR GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro. DR GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW. DR GO; GO:0003968; F:RNA-directed RNA polymerase activity; IEA:InterPro. DR GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro. DR GO; GO:0070008; F:serine-type exopeptidase activity; IEA:InterPro. DR GO; GO:0005198; F:structural molecule activity; IEA:InterPro. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:0019087; P:transformation of host cell by virus; IEA:InterPro. DR GO; GO:0019079; P:viral genome replication; IEA:InterPro. DR InterPro; IPR014001; DEAD-like_helicase. DR InterPro; IPR011492; DEAD_Flavivir. DR InterPro; IPR002521; HCV_core_C. DR InterPro; IPR002522; HCV_core_N. DR InterPro; IPR002519; HCV_env. DR InterPro; IPR002531; HCV_NS1. DR InterPro; IPR001650; Helicase_C. DR InterPro; IPR002518; Pept_C18_HCV_NS2. DR InterPro; IPR009003; Pept_cys/ser_Trypsin-like. DR InterPro; IPR004109; Peptidase_S29. DR Pfam; PF07652; Flavi_DEAD; 1. DR Pfam; PF01543; HCV_capsid; 1. DR Pfam; PF01542; HCV_core; 1. DR Pfam; PF01539; HCV_env; 1. DR Pfam; PF01560; HCV_NS1; 1. DR Pfam; PF01538; HCV_NS2; 1. DR Pfam; PF02907; Peptidase_S29; 1. DR SMART; SM00487; DEXDc; 1. DR SUPFAM; SSF50494; Pept_Ser_Cys; 1. DR PROSITE; PS51192; HELICASE_ATP_BIND_1; 1. DR PROSITE; PS51194; HELICASE_CTER; 1. PE 4: Predicted; KW ATP-binding; Capsid protein; Glycoprotein; Host membrane; KW Host-virus interaction; Hydrolase; Membrane; Nucleotide-binding; KW Protease; Ribonucleoprotein; RNA-binding; Transmembrane; KW Transmembrane helix; Viral envelope protein; Viral nucleoprotein; KW Virion. FT NON_TER 1651 1651 SQ SEQUENCE 1651 AA; 179408 MW; 19F51152A33164DD CRC64; MSTNPKPQRK TKRNTNRRPQ DVKFPGGGQI VGGVYLLPRR GPRLGVRATR KTSERSQPRG RRQPIPKARR PEGRSWAQPG YPWPLYGNEG CGWAGWLLSP RGSRPSWGPT DPRRRSRNLG KVIDTLTCGF ADLMGYIPLV GAPLGGAARA LAHGVRVLED GVNYATGNLP GCSFSIFLLA LLSCLTVPAS AYQVRNSTGL YHVTNDCPNS SIVYEAADAI LHTPGCVPCV REGNASRCWV AVTPTVATRD GKLPTTQLRR HIDLLVGSAT LCSALYVGDL CGSVFLVGQL FTFSPRRHWT TQGCNCSIYP GHITGHRMAW DMMMNWSPTA ALVVAQLLRI PQAILDMIAG AHWGVLAGMA YFSMVGNWAK VLVVLLLFAG VDAETHVSGG TAARTTARLT NLFSPGAMQN IQLVNTNGSW HINRTALNCN DSLNTGWVAG LFYRYKFNSS GCPERLASCR RLTDFAQGWG PIRYANGSGP DQRPYCWHYP PKPCGFVPAK SVCGPVYCFT PSPVVVGTTD KSGAPTYSWG ENDTDVFVLN NTRPPLGNWF GCTWMNSTGF TKVCGAPPCA IGGVGNNTLL CPTDCFRKHP EATYSRCGSG PWITPRCLVD YPYRLWHYPC TINYTIFKVR MYVGGVEHRL DAACNWTRGE RCDLEDRDRS ELSPLLLSTT QWQVLPCSFT TLPALSTGLI HLHQNIVDVQ YLYGVGSSIA SWAIKWEYVV LLFLLLADAR VCSCLWMMLL ISQAEAALEN LVILNAASLA GTHGLASFLV FFCFAWYLKG RWVPGAVYAL YGMWPLLLLS LALPQRAYAL DTEVAASCGG VVLVGLMALT LSPYYKRYIR WCMWWLQYFL TRAEAQLHIW VPPLNVRGGR DAVILLMCVA HPTLVFDITK LLLAVFGPLW ILQASLLRVP YFVRVQGLLR VCALARKLAG GHYVQMAIIK LGALTGTYVY NHLTPLRNWA HNSLQDLAVA VEPVIFSPME TKLITWGADT AACGDIINGL PVSARRGREI LLGPADGMVS KGWRLLAPIT AYAQQTRGLL GCIITSLTGR DKNQVEGEVQ IVSTAAQTFL ATCINGACWT VYHGAGTRTI ASPKGPVIQM YTNVDKDLVG WPAPQGSRSL TPCTCGSSDL YLVTRHADVI PVRRRGDSRG SLLSPRPISY LKGSSGGPLL CPAGHAVGIF RAAVCTRGVA KAVDFIPVEN LETTMRSPVF TDNSSPPAVP QSFQVAHLHA PTGSGKSTKV PAAYAAQGYK VLVLNPSVAA TLGFGAYMSK AHGIDPNIRT GVRTITTGSS ITYSTYGKFL ADGGCSGGAY DIIICDECHS VDATSILGIG TVLDQAETAG ARLVVLATAT PPGSVTVPHP NIEEVALSTT GEIPFYGKAI PLEVIKGGRH LIFCHSKRKC DELASKLVAL GVNAVAYYRG IDVSVIPTSG DVVVVATDAL MTGFTGDFDS VIDCNTCVTQ TVDFSLDPTF TIETTTLPQD AVSRTQRRGR TGRGKPGIYR FVAPGERPSG MFDSSVLCEC YDAGCAWYEL TPAETTVRLR AYMNTPGLPV CQDHLEFWEG VFTGLTHIDA HFLSQTKQSG ENFPYLVAYQ ATVCARAQAP PPSWDQMWKC LIRLKPTLQG PTPLLYRLGA VQNEVILTHP ITKYIMTCMS A //